Hyderabad-based pharma player Laurus Labs has received a licence from the Defence Research & Development Organisation (DRDO) for manufacturing and marketing Covid-19 drug 2-Deoxy-D-Glucose (2-DG) in India. The licence to Laurus Labs has been granted by DRDO as part of efforts to make the drug affordable and accessible to patients.
DRDO had recently invited expression of interest (EoI) from other pharma companies for manufacturing this drug and had said it would grant licences to 15 companies on a first-come, first-served basis. Meanwhile, the Council of Scientific & Industrial Research institution Indian Institute of Chemical Technology (CSIR-IICT) has been licencing the know-how for 2-DG synthesis to other companies, including Lee Pharma, Suven Pharma, Anthem Biosciences and Nosch Labs.
India maintained its momentum at the Asian Games 2026 in Aichi-Nagoya, Japan, on Day 2…
Goalkeeper Savita Punia of India has broken Vandana Katariya's record to become the most capped…
Gwalior is set to emerge as a significant telecom manufacturing center with the upcoming development…
Minister of Home Affairs and Minister of Cooperation Amit Shah is all set to inaugurate…
Chandni Chowk’s historic Town Hall complex is gearing up for a new beginning as the…
Smriti Mandhana scripted another history in the international cricket again as she became the leading…